FDA launches safety study for abortion pill mifepristone, source says

Article excerpt

The FDA has launched a safety study of mifepristone, the abortion pill, a senior FDA official confirmed to CBS News. The move could clear the path for the Trump administration to restrict access to the medication, which has been available in the U.S. for over two decades and accounts for roughly half of all abortions. The study's timing, coming as the new administration signals willingness to revisit abortion policy, suggests potential regulatory changes ahead, though the agency has not detailed the study's scope or timeline.